
Resources
Pharma Channel Insights: Asembia 2023 and Beyond
OnDemand
From the rising costs of distribution and dispensing obstacles to the growing presence of digital pharmacies, direct distribution, and alternative networks, pharmaceutical organizations are trying to pivot in this new environment. IntegriChain and Blue Fin Group channel experts Dave Weiss, Vice President of Industry Solutions and Bill Roth, General Manager and Founding Partner, discussed how leading pharma manufacturers are re-assessing their channel design, data, and operational capabilities needed to respond with agility.
Request a copy of the recording by emailing ic@integrichain.com.
Dave Weiss
Vice President, Industry Solutions
Bill Roth
General Manager and Founding Partner, Blue Fin Group